4,361 reports of this reaction
3.5% of all ATORVASTATIN CALCIUM, FILM COATED reports
#1 most reported adverse reaction
FATIGUE is the #1 most commonly reported adverse reaction for ATORVASTATIN CALCIUM, FILM COATED, manufactured by Accord Healthcare Inc.. There are 4,361 FDA adverse event reports linking ATORVASTATIN CALCIUM, FILM COATED to FATIGUE. This represents approximately 3.5% of all 126,371 adverse event reports for this drug.
Patients taking ATORVASTATIN CALCIUM, FILM COATED who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among ATORVASTATIN CALCIUM, FILM COATED users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for ATORVASTATIN CALCIUM, FILM COATED:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 4,361 FDA reports for ATORVASTATIN CALCIUM, FILM COATED. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.5% of all adverse event reports for ATORVASTATIN CALCIUM, FILM COATED, making it one of the most commonly reported side effect.
If you experience fatigue while taking ATORVASTATIN CALCIUM, FILM COATED, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.